New Zealand Medical Equipment Stock News

Oceania Healthcare (NZSE:OCA) has reported FY 2026 first half revenue of NZ$131.6 million with basic EPS of NZ$0.0068, setting a measured tone for its latest earnings update. The company has seen half-year revenue move between NZ$132.6 million and NZ$127.9 million over FY 2025, with basic EPS ranging from a loss of NZ$0.0236 to a profit of NZ$0.0656, giving investors a mixed earnings backdrop against which to judge the current report. With trailing 12 month net profit margins sitting near...

AFT Pharmaceuticals (NZSE:AFT) has opened FY 2026 with first half revenue of NZ$114.9 million and basic EPS of NZ$0.03, putting fresh numbers on the table for investors following its growth story. The company has seen revenue move from NZ$86.7 million and basic EPS of a NZ$0.02 loss in the first half of FY 2025 to NZ$121.3 million and basic EPS of NZ$0.14 in the second half of FY 2025, with trailing 12 month EPS most recently sitting at NZ$0.14 on revenue of NZ$254.7 million and net income of...

It's been a pretty great week for AFT Pharmaceuticals Limited ( NZSE:AFT ) shareholders, with its shares surging 11% to...

Turners Automotive Group (NZSE:TRA) opened FY 2026 with first half revenue of NZ$218.3 million and basic EPS of NZ$0.24, setting the tone for how the year is tracking versus the prior twelve months. The company has seen revenue move from NZ$204.4 million in FY 2025 H2 to NZ$218.3 million in FY 2026 H1, while basic EPS shifted from NZ$0.22 to NZ$0.24 over the same reported periods. This gives investors a clear view of performance on the top and bottom line heading into the latest release. With...

Investore Property (NZSE:IPL) has put fresh numbers on the table for FY 2026, with first half revenue of NZ$38.9 million and basic EPS of NZ$0.034 setting the tone for how the year is shaping up. The company has seen recent revenue move from NZ$37.9 million in 2H FY 2025 to NZ$38.9 million in 1H FY 2026, alongside EPS shifting from NZ$0.076 in 2H FY 2025 to NZ$0.034 in the latest half. This gives investors a clear view of how the top line and per share earnings are tracking across periods...

Tower (NZSE:TWR) has put fresh numbers on the table for H1 2026, with total revenue of NZ$309.5 million and basic EPS of NZ$0.09. This helps show how its profitability is holding up through the latest half. The company has seen revenue move from NZ$278.5 million in H1 2024 to NZ$306.9 million in H1 2025 and then to NZ$309.5 million in H2 2025, while basic EPS tracked from NZ$0.09 to NZ$0.15 and then NZ$0.09 over those same half year periods. This gives investors a clearer view of how earnings...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Radius Residential Care Limited ( NZSE:RAD ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is...

Port of Tauranga (NZSE:POT) is back in focus after New Zealand strengthened plant variety rights. This policy shift is aimed at supporting kiwifruit export growth and directly connects to the port’s role handling horticulture volumes. See our latest analysis for Port of Tauranga. At a NZ$8.30 share price, Port of Tauranga’s 30 day share price return of 2.47% and 90 day gain of 5.46% sit alongside a 1 year total shareholder return of 27.49%. Together, these figures point to steadily building...

As global markets grapple with rising inflation and higher energy costs, Asian markets are also experiencing shifts in investor sentiment. Amid these broader economic trends, penny stocks—often smaller or newer companies—remain an intriguing area for investors due to their potential for growth at lower price points. Despite being considered a somewhat outdated term, penny stocks can still offer significant opportunities when backed by strong financials and solid fundamentals.

Ryman Healthcare (NZSE:RYM) has moved into focus after its stock declined ahead of the upcoming 26 May earnings report, with investors watching closely for commentary on profitability pressures and village occupancy trends. See our latest analysis for Ryman Healthcare. Ryman Healthcare's share price has been under pressure, with the 90 day share price return down 17.34% and the year to date share price return down 30.74%, while the 5 year total shareholder return has fallen 80.81%. This...

Argosy Property (NZSE:ARG) has put fresh numbers on the table for FY 2026, with first half revenue at NZ$80.3 million, basic EPS of NZ$0.071, and Funds From Operations of NZ$32.4 million, while trailing 12 month revenue sits at NZ$159.8 million and basic EPS at NZ$0.148. Over recent halves the company has seen revenue move between NZ$78.1 million and NZ$80.3 million, with basic EPS ranging from NZ$0.0389 to NZ$0.109 as FFO per share tracked between NZ$0.0338 and NZ$0.0377. This sets up a...

Napier Port Holdings (NZSE:NPH) has laid out its H1 2026 scorecard with investors focused on how the latest half-year fits into a steadily building earnings profile, including recent trailing 12 month revenue of NZ$164.6 million and basic EPS of NZ$0.144545. Over the last three reported halves, revenue has moved from NZ$70.8 million in H2 2024 to NZ$78.1 million in H1 2025 and NZ$79.7 million in H2 2025, while basic EPS has tracked from NZ$0.047748 to NZ$0.1 and then NZ$0.054318. This sets up...

Serko (NZSE:SKO) has kicked off FY 2026 with first half revenue of NZ$61.1 million and a basic EPS loss of NZ$0.08, alongside a trailing twelve month revenue base of NZ$120.9 million and a TTM EPS loss of NZ$0.14, keeping profitability squarely in focus for investors. The company has seen revenue move from NZ$41.5 million in the first half of FY 2025 to NZ$47.0 million in the second half of FY 2025 and then to NZ$61.1 million in the first half of FY 2026. Losses have shifted from NZ$5.1...

As inflation pressures rise amid higher energy costs, Asian markets are navigating a complex landscape shaped by geopolitical uncertainties and fluctuating commodity prices. In this environment, identifying undervalued stocks can offer potential opportunities for investors seeking to capitalize on resilient sectors or companies with strong fundamentals.

Gentrack Group Limited ( NZSE:GTK ) came out with its interim results last week, and we wanted to see how the business...

Special call puts Infratil’s new contract in focus Infratil (NZSE:IFT) has scheduled a special call on 5 May 2026 to brief investors on a new contract announcement, a move that indicates the agreement could have meaningful implications for the company. See our latest analysis for Infratil. The special call comes after a strong run in the stock, with a 30 day share price return of 26.64% and a 90 day share price return of 38.48%. The 1 year total shareholder return of 33.18% and 5 year total...

Kiwi Property Group (NZSE:KPG) has put fresh numbers on the table for FY 2026, with first half revenue of NZ$136.7 million, basic EPS of NZ$0.006 and funds from operations of NZ$53.2 million setting the tone for this reporting period. Over recent halves, the company has seen revenue move from NZ$128.4 million in 1H FY 2025 to NZ$135.4 million in 2H FY 2025 and NZ$136.7 million in 1H FY 2026, while trailing twelve month EPS sits at NZ$0.0307. This gives investors a clearer view of how the...

H1 2026 earnings snapshot Gentrack Group (NZSE:GTK) has put fresh numbers on the table for H1 2026, with trailing 12 month revenue of NZ$228.3 million and basic EPS of NZ$0.172, alongside reported earnings growth of 64.9% year on year. Over recent reporting halves the company has seen revenue move from NZ$111.2 million in H2 2024 to NZ$112.0 million in H1 2025 and NZ$118.2 million in H2 2025, while basic EPS tracked from NZ$0.0407 to NZ$0.0677 and then NZ$0.1268, setting up the latest release...

Even if it's not a huge purchase, we think it was good to see that Jason Cherrington, the CEO & Director of Accordant...

Even if it's not a huge purchase, we think it was good to see that Philip Bowman, the Independent Chairman of SKY...

JPMorgan Chase & Co. recently disclosed that it now holds a substantial 5.14% stake in The a2 Milk Company, amounting to about 37.27 million ordinary shares spread across various entities and equity swaps extending into 2027. This multi-entity exposure, including long-dated equity derivatives, suggests a meaningful institutional presence in a2 Milk that could influence liquidity and how other investors assess the company’s profile. We’ll now examine how this increased institutional...

As global markets experience a rally driven by strong corporate earnings and robust performance in the information technology sector, investors are closely watching the high growth potential of tech stocks, particularly those benefiting from advancements in artificial intelligence. In this dynamic environment, identifying promising tech stocks involves evaluating companies that not only demonstrate innovation and adaptability but also exhibit resilience amid evolving economic conditions.

Pacific Edge (NZSE:PEB) has completed a NZ$25.4 million follow on equity offering at NZ$0.17 per share, a key funding step as the company works to restore Medicare coverage for its Cxbladder tests. See our latest analysis for Pacific Edge. Pacific Edge's recent follow on equity offering comes after a period of pressure on the share price, with the 30 day share price return down 11.58% and the 90 day share price return down 23.64%. However, the 1 year total shareholder return is 110%, which...